Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.

 
Web www.patentalert.com

< Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance

> Implantable medical electrical stimulation lead fixation method and apparatus

~ 00409